[1]
“Antiarrhythmic efficacy and safety of 1C class anti­­arrhythmic agents ethacizin and propafenone in patients with arterial hypertension and frequent recurrences of atrial fibrillation”, UJC, vol. 25, no. 2, pp. 43–49, May 2018, Accessed: Nov. 24, 2024. [Online]. Available: https://ucardioj.com.ua/index.php/UJC/article/view/58